- Home
- GEO vs ZLAB Comparison
GEO vs ZLAB Comparison
Compare GEO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEO | ZLAB |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GEO | ZLAB |
|---|---|---|
| Price | $14.54 | $19.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $39.67 | ★ $51.52 |
| AVG Volume (30 Days) | ★ 2.3M | 606.8K |
| Earning Date | 05-13-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 727.27 | 38.46 |
| EPS | ★ 1.82 | N/A |
| Revenue | ★ $2,263,420,000.00 | $460,156,000.00 |
| Revenue This Year | $13.89 | $19.06 |
| Revenue Next Year | $11.68 | $18.58 |
| P/E Ratio | $8.09 | ★ N/A |
| Revenue Growth | 3.85 | ★ 15.33 |
| 52 Week Low | $12.51 | $15.96 |
| 52 Week High | $32.09 | $44.34 |
Technical Indicators
Market Signals| Indicator | GEO | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | 58.27 |
| Support Level | $14.27 | $19.51 |
| Resistance Level | $17.35 | $33.34 |
| Average True Range (ATR) | 0.90 | 0.75 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 50.88 | 83.43 |
Price Performance
Historical ComparisonAbout GEO Geo Group Inc (The) REIT
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.